Zaltrap gains US approval for metastatic colorectal cancer
05:56 EDT 6 Aug 2012 | thePharmaLetter
The US Food and Drug Administration on Friday approved French drug major Sanofi (Euronext: SAN) and US partner Regeneron Pharmaceuticals' (Nasdaq: REGN) Zaltrap (ziv-aflibercept) injection for intravenous infusion, in combination with 5-fluorouracil,..
Original Article: Zaltrap gains US approval for metastatic colorectal cancer
More From BioPortfolio on "Zaltrap gains US approval for metastatic colorectal cancer"
Biotech & Healthcare Channels
World News
Life Science Events
Corporate Database
Market Reports
Categories
Search BioPortfolio:
